Aims-To use the polymerase chain reaction (PCR) to detect Chlamydia pneumoniae and Chlamydia psittaci in sputum samples. Methods-A nested PCR was developed, the first stage of which amplified DNA from both C pneumoniae and C psittaci while the second stage targeted specifically at C pneumoniae, allowing the two species to be differentiated. The primers were designed not to amplify sequences from C trachomatis. A panel of 26 sputum samples from patients with community acquired pneumonia evaluated previously by enzyme linked immunosorbent assay (ELISA), direct immunofluorescence (DIF), and culture was tested blind by PCR. Most of these specimens also had accompanying serial serum samples which were tested for species specific antibodies using microimmunofluorescence (micro-IF). Results-PCR detected C pneumoniae DNA in 10 of the 26 samples and C psittaci DNA in four. There was good concordance between ELISA, DIF, micro-IF and PCR in the C pneumoniae group. Two of the C psittaci identified by PCR were labelled Cpneumoniae by DIF but the PCR results were supported by serology or a history of bird contact. Of the PCR negative group: six were true negative results; two contained C trachomatis. There were four discrepant results. Conclusions-The data suggest that PCR is effective in the detection of C pneumoniae. The sensitivity for C psittaci is inevitably lower due to the strategy taken but specificity seemed to be good. (7 Clin Pathol 1993;46:313-317) 
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Results-PCR detected C pneumoniae DNA in 10 of the 26 samples and C psittaci DNA in four. There was good concordance between ELISA, DIF, micro-IF and PCR in the C pneumoniae group. Two of the C psittaci identified by PCR were labelled Cpneumoniae by DIF but the PCR results were supported by serology or a history of bird contact. Of the PCR negative group: six were true negative results; two contained C trachomatis. There were four discrepant results. Conclusions-The data suggest that PCR is effective in the detection of C pneumoniae. The sensitivity for C psittaci is inevitably lower due to the strategy taken but specificity seemed to be good. (7 Clin Pathol 1993; 46:313-317) Chlamydia pneumoniae and Chlamydia psittaci are important causes of lower respiratory tract infections. The reported prevalence of C Several groups have explored the possibility of detecting C pneumoniae or C psittaci using the polymerase chain reaction (PCR).'4 However, these reports provided very little information on the use of PCR on clinical specimens, particularly on sputum samples from patients with pneumonia. A method to detect and differentiate C pneumoniae and C psittaci in sputum samples using PCR has been developed.
Methods
The major outer membrane protein genes (ompA) of C pneumoniae and C psittaci were chosen as the target for amplification in a nested PCR. All primers were synthesised using an oligonucleotide synthesiser (Applied Biosystems). The outer primers (table 1) amplified a 333 base pair product from both organisms. The primers were chosen so as not to amplify the ompA gene of C trachomatis. One of the internal primers, designated CPD, was located in a variable domain of the ompA gene and was specific for C pneumoniae."' 16 Hence only the first stage product from C pneumoniae was exponentially amplified to yield the 207 base pair second stage product, allowing the two organisms to be differentiated.
Sputum samples were prepared and concentrated as described before.'7 Before PCR, the concentrated specimens were diluted ten-fold in PCR buffer (10 mM TRIS-HCI, pH 8&3, 50 mM KCl, 1-5 mM MgCl,, 0O1% Triton X-1 00) and digested with proteinase K (60 ug/ml) at 55°C for 60 minutes. After digestion, proteinase K was inactivated by heating to 1 00°C for 10 minutes and the samples were cooled on ice. Ten microlitres of the treated samples were subjected to PCR under mineral oil overlay in the same PCR buffer with 04 4,M each of CP1 and CP2 primers (table 1) , 200,iM each of dATP, dTTP, dCTP and dGTP (Pharmacia) and 2-5 units of Taq DNA polymerase (Northumbria biological laboratories). Amplification was done with a thermocycler (Perkin-Elmer) using the technique of "Touchdown" PCR'8 in which the annealing temperature was lowered 1°C every two cycles from 65°C until touching down to 55°C at which temperature 20 more cycles were performed. The denaturation temperature and the extension temperature were constant at 94°C and 72°C, respectively. The holding time at each temperature was 1 minute.
The PCR products amplified by the outer primers were diluted 10 times in water, and 10 lul was transferred to a PCR reaction mix for amplification in a second stage using the inner primers. The PCR reaction mix was the same as before except that 1 puM each of the primers CPC and CPD ( The above methods were initially evaluated and optimised using tissue culture materials from the Institute of Ophthalmology, London. All the serovars of C trachomatis, 10 strains of C psittaci (three human, four feline, one avian, one ovine, one guinea pig) and two strains of C pneumoniae (IOL 207 Discussion Isolation is frequently taken as the gold standard in microbiological practice. This may not be valid with organisms that are difficult to grow. Of the 20 chlamydial cultures attempted in this series, four isolates were made, of which only three (cases 12, 21, and 22) were definitely identified. Two of these three isolates were C trachomatis. It is recognised that specimen handling procedures used in the study were suboptimal for successful chlamydial cultivation. But the difficulty of isolating C pneumoniae from clinical specimens was well known. 6 Development of nucleic acid detection by PCR, which does not depend on organism viability, provides an alternative method of diagnosis.
C pneumoniae and C psittaci were the main foci in this PCR study. C trachomatis, which does not commonly cause pneumonia in adults and which is more easily diagnosed by conventional means, was excluded to make the procedure and its interpretation simple. In the procedure described the sputum samples required minimal treatment and no nucleic acid extraction steps were necessary. Mispriming was avoided by adopting the "Touchdown" PCR technique during the first stage.18 It was possible to complete the whole procedure within 24 hours by doing one of the PCR stages overnight.
There have been reports of PCR inhibitors being present in faeces, urine and eye swabs. 22 24 Inhibition was observed in two specimens in this series (cases 11 and 12) during the initial development phase when the specimen preparation procedure consisted only of a single heating step. The inclusion of a proteinase K digestion step prior to heating removed the inhibitor, indicating its protein nature in these two samples.
Titration studies and comparisons with DIF have suggested that this PCR approach was very sensitive for C pneumoniae. The specificity appeared to be good with high correlation with micro-IF, ELISA, and DIF. Only one of the 10 patients (case 3) identified by PCR as C pneumoniae had a history of bird contact, but results from both micro-IF and DIF suggested that the infection was with C pneumoniae rather than C psiuaci. The sensitivity of the procedure for C psittaci was inevitably lower due to the strategy chosen. The specificity was good, however, with high micro-IF correlation. There were discrepancies with DIF in two specimens in which DIF identified C pneumoniae; PCR detected C psittaci. Both patients had close bird exposure and micro-IF results supported PCR identification in one of the patients (case 13). On balance, the weight of evidence suggests that DIF may have misidentified the chlamydial species in the sputum deposits of these two patients. This problem of cross-reactivity of the C pneumoniae monoclonal antibody (Cellabs), which may partly be due to the specimen treatment procedure, has been reported before. 25 Because the detection limit of the first stage PCR was believed to be between five Both the number of specimens and the design of the study prevented comparison between the performance of ELISA, DIF, and PCR. There were two false positive results by ELISA in this series (cases 19 and 20) and this suggested that direct visualisation of elementary bodies is necessary to confirm all ELISA positive results. However, DIF of sputum smears is difficult to read requiring considerable experience particularly when there are only a few elementary bodies present. Diagnosis of C psittaci by the absence of fluorescence staining with species specific antibodies is unreliable. PCR, however, offers a viable alternative.
PCR, as developed in this study, seemed to be both sensitive and specific for C pneumoniae and also identified C psittaci with good specificity. Improvements in sensitivity for C psittaci can be made by introducing multiplex internal primers which amplify both C pneumoniae and C psittaci in the second stage. The PCR method described can serve as a confirmatory test for screening based on ELISA or DIF. It can also be used as a tool to study the role and prevalence of C pneumoniae in special patient subgroups like asthmatics and those with cystic fibrosis. Further studies could define the role of PCR in routine clinical diagnosis.
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